What is the recommended acute management for hypoxic encephalopathy?

Acute Management of Hypoxic Encephalopathy

Immediately stabilize cardiorespiratory function with head-up positioning, blood pressure support, and strict oxygenation targets while avoiding early prognostication—these interventions form the cornerstone of acute management and directly impact survival and neurological recovery. 1, 2

Immediate Stabilization (First 6 Hours)

Positioning and Hemodynamics

• Position the patient with 20–30° head-up tilt to optimize cerebral perfusion while minimizing intracranial pressure 1, 2
• Maintain systolic blood pressure >110 mmHg to prevent secondary cerebral insults and preserve cerebral blood flow 1, 2
• Use 0.9% saline as the crystalloid of choice for fluid management, as it prevents increases in brain water due to its isotonic osmolality 1, 2
• Avoid hypovolemia and hypotension, as these adversely affect neurological outcomes and patients tolerate transfers poorly when hypovolemic 1

Oxygenation and Ventilation

• Begin with the highest available FiO₂ until arterial oxyhemoglobin saturation can be reliably measured 2
• Target PaO₂ ≥13 kPa (approximately 98 mmHg) to prevent hypoxemia, which significantly worsens neurological outcomes 1
• Once monitoring is established, target arterial oxygen saturation of 94–98% and avoid hyperoxia (PaO₂ >300 mmHg), as it aggravates free-radical neuronal injury 2
• Maintain PaCO₂ at 4.5–5.0 kPa (35–45 mmHg, normocapnia), as both hypercapnia (>50 mmHg) and hypocapnia (<30 mmHg) are independently associated with worse survival and neurological outcomes 1, 2
• Avoid hyperventilation except for short-term use when there is evidence of raised intracranial pressure with impending herniation (PaCO₂ not less than 4 kPa), as it induces cerebral vasoconstriction and worsens ischemia 1, 2

Temperature Management

• Initiate targeted temperature management (therapeutic hypothermia) within 6 hours of the hypoxic event for moderate to severe hypoxic-ischemic encephalopathy 2, 3, 4
• Maintain strict temperature control at 33–34°C for 72 hours, as this is the standard of care and reduces the risk of death or major neurodevelopmental disability by approximately 22–33% 2, 4
• Rewarm gradually over at least 4 hours after the 72-hour cooling period to prevent complications 1, 2
• Actively prevent fever throughout the acute phase and after rewarming, as hyperthermia increases complications and is associated with unfavorable clinical outcomes including death 1, 2

Glucose Management

• Maintain blood glucose within normal range, avoiding hyperglycemia >180 mg/dL and hypoglycemia, as both extremes worsen brain injury 2

Neurological Monitoring and Seizure Management

EEG Monitoring

• Perform prompt EEG in all comatose patients to diagnose seizures, as subclinical seizures are common and may worsen outcomes 2, 5
• Implement continuous or frequent EEG monitoring, especially when neuromuscular blockade is used, as clinical seizure detection is unreliable 2, 5
• Use EEG to differentiate hypoactive delirium from treatable non-convulsive status epilepticus 2

Seizure Treatment

• Treat non-convulsive status epilepticus identified on EEG even in patients with poor prognosis, using standard anticonvulsant regimens 2
• Phenobarbital remains the first-line treatment for neonatal seizures according to International League Against Epilepsy guidelines 5
• Administer anticonvulsant therapy at sufficiently high doses and for sufficiently long periods 2
• Consider alternative administration routes (buccal, intramuscular, subcutaneous, rectal) in palliative settings 2
• Treat epileptic seizures that affect quality of life, even with poor prognosis 2

Important caveat: The 2024 ILCOR guidelines found very low certainty evidence for prophylactic antiseizure medication post-cardiac arrest, with no clear benefit on survival with favorable neurological outcome 6. Therefore, do not use prophylactic antiseizure medications—only treat confirmed seizures identified on EEG.

Observation Period for Devastating Brain Injury

• Provide a period of physiological stabilization and observation (typically 72 hours or longer) before making definitive prognostic decisions, as early prognostication is often inaccurate 6, 1
• Admit intubated patients to critical care for this observation period unless comorbidities make continued organ support futile regardless of neurological recovery potential 6, 1
• During observation, the therapeutic aim is cardiorespiratory stability to facilitate accurate neurological prognostication 6, 1
• If neurological function continues to deteriorate despite cardiorespiratory stability, the multidisciplinary team may consider this an appropriate trigger for withdrawal of life-sustaining therapy 6

Prognostication Guidelines

Timing and Confounders

• Delay prognostication until at least 72 hours after return to normothermia in patients who received targeted temperature management, as sedation and paralysis confound clinical examination 2, 7
• In patients not treated with targeted temperature management, the earliest reliable clinical prognostication is 72 hours after cardiac arrest 2
• Eliminate all confounding factors before prognostication, including residual sedatives, significant electrolyte disturbances, and ongoing hypothermia 1, 2, 7
• Avoid early prognostication to prevent self-fulfilling prophecy bias, where negative test results lead to premature withdrawal of care that might have been beneficial 1, 2, 7

Multimodal Prognostic Approach

Use a comprehensive approach with no single factor serving as the sole indicator, combining: 2, 7

Clinical examination:

• Absence of pupillary and corneal reflexes at ≥72 hours strongly suggests unfavorable outcome 1, 7
• Status myoclonus within 72 hours is associated with poor prognosis 1, 7

Electrophysiological tests:

• Bilateral absence of N20 cortical waves on somatosensory evoked potentials (SSEP) at ≥24 hours strongly indicates poor outcome 1, 7
• Highly malignant EEG patterns at >24 hours are associated with unfavorable outcomes 7

Biomarkers:

• Neuron-specific enolase (NSE) levels >60 μg/L at 48 or 72 hours indicate poor prognosis 1, 7
• In ECMO patients, NSE thresholds may exceed 100 μg/L due to ongoing hemolysis 7

Neuroimaging:

• Extensive diffuse anoxic injury on brain CT/MRI is associated with poor outcomes 1, 7
• Obtain urgent non-contrast head CT to evaluate injury extent and rule out intracranial hemorrhage 2

Poor prognosis is indicated by at least two of the following: absent pupillary and corneal reflexes at ≥72h, bilateral absence of N20 SSEP responses at ≥24h, highly malignant EEG pattern at >24h, NSE >60 μg/L at 48h or 72h, status myoclonus ≤72h, or extensive diffuse anoxic injury on neuroimaging 7

Delirium Management

• Implement environmental measures including a calm environment, orientation cues, fall prophylaxis, and calm communication to reduce delirium 2
• Base pharmacologic decisions on symptom burden and impact on quality of life rather than routine administration 2

Common Pitfalls to Avoid

• Never rely on a single prognostic indicator, as this leads to inaccurate predictions 1, 7
• Prevent even brief periods of hypoxia, as they exacerbate secondary brain injury 1
• Avoid the self-fulfilling prophecy bias where early negative prognostication leads to withdrawal of care that might have been beneficial 1, 7
• Do not use prophylactic antiseizure medications, as evidence shows no benefit and potential harm; only treat confirmed seizures 6, 2
• Remember that therapeutic hypothermia must be conducted in level III or IV neonatal intensive care units with multidisciplinary care capabilities, including intravenous therapy, respiratory support, pulse oximetry, antibiotics, anticonvulsants, and pathology testing 2, 4